Aggregate Asset Value: AstraZeneca Plc (AZN)

Corporate emblem and logo of AstraZeneca Plc (AZN)

This daily price chart for AstraZeneca PLC (AZN) illustrates total assets at 114163.93. The business relies on partnerships with external contractors for vaccine production and testing. A balanced product portfolio in cardiology and oncology ensures stability by eliminating patent risks. Growth is driven by successes in rare disease therapies and expansion into promising regional markets.

AZN: astrazeneca.com Aggregate Company Assets 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for AstraZeneca AB (AZN)

- price and consensus price forecast:
Quote Chart astrazeneca.com|AZN - Analyst Consensus Forecast
- market capitalization data:
Market Value AstraZeneca Corp.|AZN - Enterprise Value
- book capitalization data:
Book Value per Share AstraZeneca|AZN - Company Book Value|Market Value to Book Value astrazeneca.com|AZN - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio AstraZeneca PLC|AZN - Long-Term Debt to Capital|Short-Term Debt to Capital AstraZeneca Corp.|AZN - Company Total Debt|Debt to Net Assets Ratio AstraZeneca Corp.|AZN - Company Long-Term Debts|Company Short-Term Loans and Borrowings AstraZeneca
Analysis of all company metrics:AstraZeneca PLC
Manufactured product of AstraZeneca AB

Total assets represent the aggregate of all resources and liabilities, calculated reverse-engineered via ROA to identify the business's vector dynamics. This metric allows investors to assess the scale of AstraZeneca PLC (AZN) expansion relative to industry competitors. By analyzing fluctuations in total capital and liabilities, one can determine phases of cyclical growth or stagnation. For AstraZeneca PLC (AZN), this reflects the capital intensity of transitioning to carbon-negative production and the modernization of sustainable logistics.

Competitors of AstraZeneca PLC (AZN)

lilly.com (LLY) - Total Asset Value of Company|ABBV - Company Total Assets|Aggregate Asset Value Novartis Corporation|Company Total Assets MRK|Company Total Assets NVO (Novo Nordisk Group)|Aggregate Company Assets Amgen Inc.|pfizer.com - Aggregate Asset Value|SNY: Aggregate Company Assets|BMY - Cumulative Company Assets|GSK: Company Total Assets|Company Total Assets Takeda Pharma|TEVA - Cumulative Company Assets|Aggregate Asset Value drreddys.com|Viatris (VTRS) - Company Total Assets|Aggregate Asset Value ROIV (Roivant)|ZLAB: Aggregate Company Assets|Bausch Health Corp - Company Assets|COSM - Aggregate Company Assets